Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Why is LDL control important?

Malnutrition and frailty in older adults - The importance of screening and early intervention

Heart failure and obesity - Which do we manage first?

The social media ban - Practical preparation for children and family

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis